nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC10A2—esophageal cancer	0.875	1	CbGaD
Valaciclovir—SLC22A8—Methotrexate—esophageal cancer	0.0123	0.589	CbGbCtD
Valaciclovir—SLC22A6—Methotrexate—esophageal cancer	0.00856	0.411	CbGbCtD
Valaciclovir—Thrombotic microangiopathy—Cisplatin—esophageal cancer	0.00569	0.0745	CcSEcCtD
Valaciclovir—Aciclovir—SLC10A2—esophageal cancer	0.00493	1	CrCbGaD
Valaciclovir—Cytomegalovirus infection—Methotrexate—esophageal cancer	0.00373	0.0489	CcSEcCtD
Valaciclovir—Haemolytic uraemic syndrome—Cisplatin—esophageal cancer	0.00327	0.0428	CcSEcCtD
Valaciclovir—Neurological symptom—Cisplatin—esophageal cancer	0.00236	0.0309	CcSEcCtD
Valaciclovir—Immunodeficiency—Methotrexate—esophageal cancer	0.00226	0.0296	CcSEcCtD
Valaciclovir—SLC6A14—digestive system—esophageal cancer	0.00122	0.272	CbGeAlD
Valaciclovir—Altered state of consciousness—Capecitabine—esophageal cancer	0.00114	0.0149	CcSEcCtD
Valaciclovir—Rectal disorder—Capecitabine—esophageal cancer	0.00107	0.014	CcSEcCtD
Valaciclovir—SLC6A14—lung—esophageal cancer	0.00102	0.227	CbGeAlD
Valaciclovir—Anorectal disorder—Capecitabine—esophageal cancer	0.001	0.0131	CcSEcCtD
Valaciclovir—Platelet count decreased—Capecitabine—esophageal cancer	0.000884	0.0116	CcSEcCtD
Valaciclovir—Rhinorrhoea—Cisplatin—esophageal cancer	0.000881	0.0115	CcSEcCtD
Valaciclovir—Infection—Carboplatin—esophageal cancer	0.000862	0.0113	CcSEcCtD
Valaciclovir—Raised liver function tests—Methotrexate—esophageal cancer	0.000848	0.0111	CcSEcCtD
Valaciclovir—Encephalopathy—Capecitabine—esophageal cancer	0.000819	0.0107	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—ALDH3A1—esophageal cancer	0.000814	0.045	CbGpPWpGaD
Valaciclovir—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.000798	0.0105	CcSEcCtD
Valaciclovir—SLC10A2—digestive system—esophageal cancer	0.000792	0.177	CbGeAlD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000763	0.0422	CbGpPWpGaD
Valaciclovir—Dysarthria—Cisplatin—esophageal cancer	0.000754	0.00988	CcSEcCtD
Valaciclovir—Pain—Carboplatin—esophageal cancer	0.000742	0.00972	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—BLVRB—esophageal cancer	0.000725	0.0401	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000697	0.0386	CbGpPWpGaD
Valaciclovir—Body temperature increased—Carboplatin—esophageal cancer	0.000686	0.00899	CcSEcCtD
Valaciclovir—Rhinorrhoea—Capecitabine—esophageal cancer	0.000649	0.0085	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—PRDX1—esophageal cancer	0.000617	0.0341	CbGpPWpGaD
Valaciclovir—Encephalopathy—Methotrexate—esophageal cancer	0.00061	0.00799	CcSEcCtD
Valaciclovir—Herpes simplex—Capecitabine—esophageal cancer	0.000571	0.00748	CcSEcCtD
Valaciclovir—Renal failure acute—Cisplatin—esophageal cancer	0.000561	0.00735	CcSEcCtD
Valaciclovir—Dysarthria—Capecitabine—esophageal cancer	0.000556	0.00728	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—SLC39A6—esophageal cancer	0.00055	0.0304	CbGpPWpGaD
Valaciclovir—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000526	0.00689	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—ADH7—esophageal cancer	0.000525	0.029	CbGpPWpGaD
Valaciclovir—Depressed level of consciousness—Capecitabine—esophageal cancer	0.000508	0.00665	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.0005	0.0277	CbGpPWpGaD
Valaciclovir—Face oedema—Cisplatin—esophageal cancer	0.0005	0.00655	CcSEcCtD
Valaciclovir—Blood creatinine increased—Cisplatin—esophageal cancer	0.000485	0.00636	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—esophageal cancer	0.000484	0.0268	CbGpPWpGaD
Valaciclovir—Dehydration—Cisplatin—esophageal cancer	0.000482	0.00631	CcSEcCtD
Valaciclovir—Mouth ulceration—Capecitabine—esophageal cancer	0.000475	0.00623	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000466	0.00611	CcSEcCtD
Valaciclovir—Nasopharyngitis—Cisplatin—esophageal cancer	0.000463	0.00607	CcSEcCtD
Valaciclovir—Sleep disorder—Capecitabine—esophageal cancer	0.000441	0.00578	CcSEcCtD
Valaciclovir—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000439	0.00575	CcSEcCtD
Valaciclovir—Photosensitivity—Capecitabine—esophageal cancer	0.000435	0.0057	CcSEcCtD
Valaciclovir—Abdominal discomfort—Cisplatin—esophageal cancer	0.000429	0.00562	CcSEcCtD
Valaciclovir—Herpes simplex—Methotrexate—esophageal cancer	0.000425	0.00557	CcSEcCtD
Valaciclovir—Dysarthria—Methotrexate—esophageal cancer	0.000414	0.00542	CcSEcCtD
Valaciclovir—Renal failure acute—Capecitabine—esophageal cancer	0.000413	0.00542	CcSEcCtD
Valaciclovir—SLC15A1—epithelium—esophageal cancer	0.000404	0.0901	CbGeAlD
Valaciclovir—Renal impairment—Capecitabine—esophageal cancer	0.000401	0.00525	CcSEcCtD
Valaciclovir—Renal failure—Cisplatin—esophageal cancer	0.000392	0.00514	CcSEcCtD
Valaciclovir—Stomatitis—Cisplatin—esophageal cancer	0.000389	0.0051	CcSEcCtD
Valaciclovir—Osteoarthritis—Capecitabine—esophageal cancer	0.000382	0.005	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—ABCC2—esophageal cancer	0.000381	0.0211	CbGpPWpGaD
Valaciclovir—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000378	0.00495	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000377	0.00494	CcSEcCtD
Valaciclovir—Migraine—Capecitabine—esophageal cancer	0.000376	0.00492	CcSEcCtD
Valaciclovir—Face oedema—Capecitabine—esophageal cancer	0.000369	0.00483	CcSEcCtD
Valaciclovir—Aplastic anaemia—Methotrexate—esophageal cancer	0.000368	0.00482	CcSEcCtD
Valaciclovir—Ataxia—Capecitabine—esophageal cancer	0.000359	0.0047	CcSEcCtD
Valaciclovir—Coma—Methotrexate—esophageal cancer	0.000358	0.00469	CcSEcCtD
Valaciclovir—Blood creatinine increased—Capecitabine—esophageal cancer	0.000358	0.00469	CcSEcCtD
Valaciclovir—Dehydration—Capecitabine—esophageal cancer	0.000355	0.00465	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—NFE2L2—esophageal cancer	0.000354	0.0196	CbGpPWpGaD
Valaciclovir—Mouth ulceration—Methotrexate—esophageal cancer	0.000354	0.00464	CcSEcCtD
Valaciclovir—Urinary tract disorder—Cisplatin—esophageal cancer	0.000354	0.00464	CcSEcCtD
Valaciclovir—Liver function test abnormal—Capecitabine—esophageal cancer	0.000352	0.00462	CcSEcCtD
Valaciclovir—Urethral disorder—Cisplatin—esophageal cancer	0.000351	0.0046	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000347	0.0192	CbGpPWpGaD
Valaciclovir—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000344	0.0045	CcSEcCtD
Valaciclovir—Nasopharyngitis—Capecitabine—esophageal cancer	0.000341	0.00447	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000337	0.00441	CcSEcCtD
Valaciclovir—Influenza—Capecitabine—esophageal cancer	0.00033	0.00432	CcSEcCtD
Valaciclovir—Photosensitivity—Methotrexate—esophageal cancer	0.000324	0.00424	CcSEcCtD
Valaciclovir—Immune system disorder—Cisplatin—esophageal cancer	0.000324	0.00424	CcSEcCtD
Valaciclovir—Mediastinal disorder—Cisplatin—esophageal cancer	0.000323	0.00423	CcSEcCtD
Valaciclovir—Bronchitis—Capecitabine—esophageal cancer	0.000317	0.00416	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000317	0.0175	CbGpPWpGaD
Valaciclovir—Alopecia—Cisplatin—esophageal cancer	0.000317	0.00415	CcSEcCtD
Valaciclovir—Abdominal discomfort—Capecitabine—esophageal cancer	0.000316	0.00414	CcSEcCtD
Valaciclovir—Renal failure acute—Methotrexate—esophageal cancer	0.000308	0.00403	CcSEcCtD
Valaciclovir—Flatulence—Cisplatin—esophageal cancer	0.000307	0.00403	CcSEcCtD
Valaciclovir—SLC15A1—digestive system—esophageal cancer	0.000307	0.0685	CbGeAlD
Valaciclovir—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000307	0.00402	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—CYP2A6—esophageal cancer	0.000305	0.0169	CbGpPWpGaD
Valaciclovir—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000301	0.00395	CcSEcCtD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000298	0.0165	CbGpPWpGaD
Valaciclovir—Depression—Capecitabine—esophageal cancer	0.000293	0.00384	CcSEcCtD
Valaciclovir—Tremor—Cisplatin—esophageal cancer	0.000292	0.00383	CcSEcCtD
Valaciclovir—Renal failure—Capecitabine—esophageal cancer	0.000289	0.00379	CcSEcCtD
Valaciclovir—Anaemia—Cisplatin—esophageal cancer	0.000288	0.00378	CcSEcCtD
Valaciclovir—Stomatitis—Capecitabine—esophageal cancer	0.000287	0.00376	CcSEcCtD
Valaciclovir—Urinary tract infection—Capecitabine—esophageal cancer	0.000286	0.00375	CcSEcCtD
Valaciclovir—Osteoarthritis—Methotrexate—esophageal cancer	0.000284	0.00372	CcSEcCtD
Valaciclovir—Haematuria—Capecitabine—esophageal cancer	0.00028	0.00367	CcSEcCtD
Valaciclovir—Leukopenia—Cisplatin—esophageal cancer	0.000279	0.00366	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000278	0.00364	CcSEcCtD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000272	0.0151	CbGpPWpGaD
Valaciclovir—Convulsion—Cisplatin—esophageal cancer	0.00027	0.00354	CcSEcCtD
Valaciclovir—Ataxia—Methotrexate—esophageal cancer	0.000267	0.0035	CcSEcCtD
Valaciclovir—Myalgia—Cisplatin—esophageal cancer	0.000266	0.00348	CcSEcCtD
Valaciclovir—Rhinitis—Capecitabine—esophageal cancer	0.000265	0.00347	CcSEcCtD
Valaciclovir—Hepatitis—Capecitabine—esophageal cancer	0.000264	0.00346	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000264	0.00345	CcSEcCtD
Valaciclovir—Liver function test abnormal—Methotrexate—esophageal cancer	0.000262	0.00344	CcSEcCtD
Valaciclovir—Pharyngitis—Capecitabine—esophageal cancer	0.000262	0.00343	CcSEcCtD
Valaciclovir—Urinary tract disorder—Capecitabine—esophageal cancer	0.000261	0.00342	CcSEcCtD
Valaciclovir—Oedema peripheral—Capecitabine—esophageal cancer	0.00026	0.00341	CcSEcCtD
Valaciclovir—Urethral disorder—Capecitabine—esophageal cancer	0.000259	0.00339	CcSEcCtD
Valaciclovir—Oedema—Cisplatin—esophageal cancer	0.000255	0.00333	CcSEcCtD
Valaciclovir—Anaphylactic shock—Cisplatin—esophageal cancer	0.000255	0.00333	CcSEcCtD
Valaciclovir—Infection—Cisplatin—esophageal cancer	0.000253	0.00331	CcSEcCtD
Valaciclovir—Erythema multiforme—Capecitabine—esophageal cancer	0.00025	0.00327	CcSEcCtD
Valaciclovir—Nervous system disorder—Cisplatin—esophageal cancer	0.00025	0.00327	CcSEcCtD
Valaciclovir—Thrombocytopenia—Cisplatin—esophageal cancer	0.000249	0.00326	CcSEcCtD
Valaciclovir—SLC15A2—bronchus—esophageal cancer	0.000249	0.0555	CbGeAlD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000248	0.0137	CbGpPWpGaD
Valaciclovir—Tachycardia—Cisplatin—esophageal cancer	0.000248	0.00325	CcSEcCtD
Valaciclovir—Skin disorder—Cisplatin—esophageal cancer	0.000247	0.00324	CcSEcCtD
Valaciclovir—Anorexia—Cisplatin—esophageal cancer	0.000243	0.00318	CcSEcCtD
Valaciclovir—Immune system disorder—Capecitabine—esophageal cancer	0.000239	0.00313	CcSEcCtD
Valaciclovir—Mediastinal disorder—Capecitabine—esophageal cancer	0.000238	0.00312	CcSEcCtD
Valaciclovir—Chills—Capecitabine—esophageal cancer	0.000237	0.0031	CcSEcCtD
Valaciclovir—Abdominal discomfort—Methotrexate—esophageal cancer	0.000235	0.00308	CcSEcCtD
Valaciclovir—Alopecia—Capecitabine—esophageal cancer	0.000233	0.00306	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000232	0.00304	CcSEcCtD
Valaciclovir—Paraesthesia—Cisplatin—esophageal cancer	0.000229	0.00299	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000228	0.00299	CcSEcCtD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000227	0.0126	CbGpPWpGaD
Valaciclovir—Dyspnoea—Cisplatin—esophageal cancer	0.000227	0.00297	CcSEcCtD
Valaciclovir—Flatulence—Capecitabine—esophageal cancer	0.000227	0.00297	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000224	0.00294	CcSEcCtD
Valaciclovir—SLC15A2—trachea—esophageal cancer	0.000223	0.0498	CbGeAlD
Valaciclovir—Back pain—Capecitabine—esophageal cancer	0.000222	0.00291	CcSEcCtD
Valaciclovir—Decreased appetite—Cisplatin—esophageal cancer	0.000221	0.0029	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00022	0.00288	CcSEcCtD
Valaciclovir—Depression—Methotrexate—esophageal cancer	0.000218	0.00286	CcSEcCtD
Valaciclovir—Pain—Cisplatin—esophageal cancer	0.000218	0.00285	CcSEcCtD
Valaciclovir—Tremor—Capecitabine—esophageal cancer	0.000215	0.00282	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—esophageal cancer	0.000215	0.00282	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—TGFBR2—esophageal cancer	0.000214	0.0118	CbGpPWpGaD
Valaciclovir—Stomatitis—Methotrexate—esophageal cancer	0.000213	0.0028	CcSEcCtD
Valaciclovir—Anaemia—Capecitabine—esophageal cancer	0.000212	0.00278	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—HMOX1—esophageal cancer	0.000211	0.0117	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Cisplatin—esophageal cancer	0.00021	0.00275	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—esophageal cancer	0.000209	0.00274	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000207	0.00271	CcSEcCtD
Valaciclovir—Leukopenia—Capecitabine—esophageal cancer	0.000206	0.0027	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000203	0.0112	CbGpPWpGaD
Valaciclovir—Body temperature increased—Cisplatin—esophageal cancer	0.000201	0.00264	CcSEcCtD
Valaciclovir—Cough—Capecitabine—esophageal cancer	0.000201	0.00263	CcSEcCtD
Valaciclovir—Hypertension—Capecitabine—esophageal cancer	0.000198	0.0026	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000198	0.0109	CbGpPWpGaD
Valaciclovir—Hepatitis—Methotrexate—esophageal cancer	0.000197	0.00258	CcSEcCtD
Valaciclovir—Chest pain—Capecitabine—esophageal cancer	0.000196	0.00256	CcSEcCtD
Valaciclovir—Arthralgia—Capecitabine—esophageal cancer	0.000196	0.00256	CcSEcCtD
Valaciclovir—Myalgia—Capecitabine—esophageal cancer	0.000196	0.00256	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—esophageal cancer	0.000195	0.00256	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000194	0.00255	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—esophageal cancer	0.000194	0.00254	CcSEcCtD
Valaciclovir—SLC10A2—Orphan transporters—CREBBP—esophageal cancer	0.000194	0.0107	CbGpPWpGaD
Valaciclovir—Urethral disorder—Methotrexate—esophageal cancer	0.000193	0.00252	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000193	0.0107	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.000192	0.0106	CbGpPWpGaD
Valaciclovir—Dry mouth—Capecitabine—esophageal cancer	0.000191	0.00251	CcSEcCtD
Valaciclovir—Confusional state—Capecitabine—esophageal cancer	0.000189	0.00248	CcSEcCtD
Valaciclovir—Oedema—Capecitabine—esophageal cancer	0.000188	0.00246	CcSEcCtD
Valaciclovir—Hypersensitivity—Cisplatin—esophageal cancer	0.000188	0.00246	CcSEcCtD
Valaciclovir—Infection—Capecitabine—esophageal cancer	0.000186	0.00244	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—esophageal cancer	0.000186	0.00244	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000186	0.0103	CbGpPWpGaD
Valaciclovir—Nervous system disorder—Capecitabine—esophageal cancer	0.000184	0.00241	CcSEcCtD
Valaciclovir—Thrombocytopenia—Capecitabine—esophageal cancer	0.000184	0.00241	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000184	0.0102	CbGpPWpGaD
Valaciclovir—Tachycardia—Capecitabine—esophageal cancer	0.000183	0.0024	CcSEcCtD
Valaciclovir—Asthenia—Cisplatin—esophageal cancer	0.000183	0.00239	CcSEcCtD
Valaciclovir—Skin disorder—Capecitabine—esophageal cancer	0.000182	0.00239	CcSEcCtD
Valaciclovir—Anorexia—Capecitabine—esophageal cancer	0.000179	0.00234	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—esophageal cancer	0.000178	0.00233	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—esophageal cancer	0.000177	0.00232	CcSEcCtD
Valaciclovir—Chills—Methotrexate—esophageal cancer	0.000176	0.00231	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000176	0.00974	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000176	0.00974	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000176	0.00974	CbGpPWpGaD
Valaciclovir—Diarrhoea—Cisplatin—esophageal cancer	0.000174	0.00228	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—esophageal cancer	0.000174	0.00228	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000171	0.00224	CcSEcCtD
Valaciclovir—Insomnia—Capecitabine—esophageal cancer	0.00017	0.00222	CcSEcCtD
Valaciclovir—Paraesthesia—Capecitabine—esophageal cancer	0.000168	0.00221	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000168	0.00929	CbGpPWpGaD
Valaciclovir—Dyspnoea—Capecitabine—esophageal cancer	0.000167	0.00219	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—esophageal cancer	0.000166	0.00217	CcSEcCtD
Valaciclovir—Dyspepsia—Capecitabine—esophageal cancer	0.000165	0.00216	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000164	0.00907	CbGpPWpGaD
Valaciclovir—Decreased appetite—Capecitabine—esophageal cancer	0.000163	0.00214	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000162	0.00212	CcSEcCtD
Valaciclovir—Vomiting—Cisplatin—esophageal cancer	0.000162	0.00212	CcSEcCtD
Valaciclovir—Fatigue—Capecitabine—esophageal cancer	0.000162	0.00212	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000161	0.00891	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000161	0.00891	CbGpPWpGaD
Valaciclovir—Rash—Cisplatin—esophageal cancer	0.00016	0.0021	CcSEcCtD
Valaciclovir—Constipation—Capecitabine—esophageal cancer	0.00016	0.0021	CcSEcCtD
Valaciclovir—Pain—Capecitabine—esophageal cancer	0.00016	0.0021	CcSEcCtD
Valaciclovir—SLC15A2—lung—esophageal cancer	0.00016	0.0358	CbGeAlD
Valaciclovir—Dermatitis—Cisplatin—esophageal cancer	0.00016	0.0021	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—esophageal cancer	0.000158	0.00207	CcSEcCtD
Valaciclovir—Feeling abnormal—Capecitabine—esophageal cancer	0.000155	0.00203	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000153	0.00849	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000153	0.00201	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—esophageal cancer	0.000153	0.00201	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000152	0.00842	CbGpPWpGaD
Valaciclovir—Nausea—Cisplatin—esophageal cancer	0.000151	0.00198	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00015	0.00829	CbGpPWpGaD
Valaciclovir—Cough—Methotrexate—esophageal cancer	0.000149	0.00196	CcSEcCtD
Valaciclovir—Urticaria—Capecitabine—esophageal cancer	0.000149	0.00195	CcSEcCtD
Valaciclovir—Abdominal pain—Capecitabine—esophageal cancer	0.000148	0.00194	CcSEcCtD
Valaciclovir—Body temperature increased—Capecitabine—esophageal cancer	0.000148	0.00194	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—esophageal cancer	0.000148	0.00194	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—esophageal cancer	0.000146	0.00191	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—esophageal cancer	0.000146	0.00191	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—esophageal cancer	0.000146	0.00191	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000145	0.0019	CcSEcCtD
Valaciclovir—Confusional state—Methotrexate—esophageal cancer	0.000141	0.00185	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—esophageal cancer	0.00014	0.00183	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000139	0.0077	CbGpPWpGaD
Valaciclovir—Infection—Methotrexate—esophageal cancer	0.000139	0.00182	CcSEcCtD
Valaciclovir—Hypersensitivity—Capecitabine—esophageal cancer	0.000138	0.00181	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—esophageal cancer	0.000137	0.00179	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—esophageal cancer	0.000137	0.00179	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—esophageal cancer	0.000136	0.00178	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000135	0.00748	CbGpPWpGaD
Valaciclovir—Asthenia—Capecitabine—esophageal cancer	0.000135	0.00176	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000134	0.00741	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000133	0.00738	CbGpPWpGaD
Valaciclovir—Anorexia—Methotrexate—esophageal cancer	0.000133	0.00174	CcSEcCtD
Valaciclovir—Pruritus—Capecitabine—esophageal cancer	0.000133	0.00174	CcSEcCtD
Valaciclovir—Diarrhoea—Capecitabine—esophageal cancer	0.000128	0.00168	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000127	0.00167	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—esophageal cancer	0.000126	0.00165	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—esophageal cancer	0.000125	0.00164	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—esophageal cancer	0.000125	0.00163	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—esophageal cancer	0.000124	0.00163	CcSEcCtD
Valaciclovir—Dizziness—Capecitabine—esophageal cancer	0.000124	0.00163	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000124	0.00685	CbGpPWpGaD
Valaciclovir—Dyspepsia—Methotrexate—esophageal cancer	0.000123	0.00161	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000122	0.00675	CbGpPWpGaD
Valaciclovir—Decreased appetite—Methotrexate—esophageal cancer	0.000121	0.00159	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000121	0.0067	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000121	0.00158	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—esophageal cancer	0.00012	0.00158	CcSEcCtD
Valaciclovir—Pain—Methotrexate—esophageal cancer	0.000119	0.00156	CcSEcCtD
Valaciclovir—Vomiting—Capecitabine—esophageal cancer	0.000119	0.00156	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SLC52A3—esophageal cancer	0.000119	0.00658	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BLVRB—esophageal cancer	0.000119	0.00658	CbGpPWpGaD
Valaciclovir—Rash—Capecitabine—esophageal cancer	0.000118	0.00155	CcSEcCtD
Valaciclovir—Dermatitis—Capecitabine—esophageal cancer	0.000118	0.00155	CcSEcCtD
Valaciclovir—Headache—Capecitabine—esophageal cancer	0.000118	0.00154	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—esophageal cancer	0.000115	0.00151	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000114	0.0015	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000113	0.00625	CbGpPWpGaD
Valaciclovir—Nausea—Capecitabine—esophageal cancer	0.000111	0.00146	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—esophageal cancer	0.000111	0.00145	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000111	0.00613	CbGpPWpGaD
Valaciclovir—Body temperature increased—Methotrexate—esophageal cancer	0.00011	0.00145	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—esophageal cancer	0.00011	0.00145	CcSEcCtD
Valaciclovir—SLC15A2—lymph node—esophageal cancer	0.00011	0.0245	CbGeAlD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000106	0.00588	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000103	0.00571	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Methotrexate—esophageal cancer	0.000103	0.00135	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CA1—esophageal cancer	0.000101	0.0056	CbGpPWpGaD
Valaciclovir—Asthenia—Methotrexate—esophageal cancer	0.0001	0.00131	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—esophageal cancer	9.88e-05	0.00129	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—esophageal cancer	9.56e-05	0.00125	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	9.34e-05	0.00517	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CA2—esophageal cancer	9.25e-05	0.00512	CbGpPWpGaD
Valaciclovir—Dizziness—Methotrexate—esophageal cancer	9.24e-05	0.00121	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	9.04e-05	0.005	CbGpPWpGaD
Valaciclovir—Vomiting—Methotrexate—esophageal cancer	8.88e-05	0.00116	CcSEcCtD
Valaciclovir—Rash—Methotrexate—esophageal cancer	8.81e-05	0.00115	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—esophageal cancer	8.8e-05	0.00115	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	8.79e-05	0.00486	CbGpPWpGaD
Valaciclovir—Headache—Methotrexate—esophageal cancer	8.75e-05	0.00115	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	8.67e-05	0.0048	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLCE1—esophageal cancer	8.6e-05	0.00476	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ADH7—esophageal cancer	8.6e-05	0.00476	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.5e-05	0.0047	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	8.33e-05	0.00461	CbGpPWpGaD
Valaciclovir—Nausea—Methotrexate—esophageal cancer	8.3e-05	0.00109	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	8.15e-05	0.00451	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.95e-05	0.0044	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	7.73e-05	0.00428	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	7.71e-05	0.00427	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.62e-05	0.00421	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.62e-05	0.00421	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ADH1B—esophageal cancer	7.54e-05	0.00417	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.38e-05	0.00408	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.37e-05	0.00408	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.25e-05	0.00401	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TYMP—esophageal cancer	7.21e-05	0.00399	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.08e-05	0.00392	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.07e-05	0.00391	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.07e-05	0.00391	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP26A1—esophageal cancer	7.01e-05	0.00388	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	6.87e-05	0.0038	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALOX15—esophageal cancer	6.83e-05	0.00378	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.75e-05	0.00373	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.56e-05	0.00363	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTO1—esophageal cancer	6.52e-05	0.00361	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TPI1—esophageal cancer	6.52e-05	0.00361	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.48e-05	0.00358	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	6.44e-05	0.00356	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.29e-05	0.00348	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.29e-05	0.00348	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALDOB—esophageal cancer	6.25e-05	0.00346	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	6.05e-05	0.00335	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GAPDH—esophageal cancer	6.02e-05	0.00333	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CRABP1—esophageal cancer	5.96e-05	0.0033	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.77e-05	0.00319	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	5.74e-05	0.00317	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GNG7—esophageal cancer	5.67e-05	0.00314	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	5.47e-05	0.00303	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.36e-05	0.00296	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALDH2—esophageal cancer	5.31e-05	0.00294	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	5.25e-05	0.0029	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	5.25e-05	0.0029	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.24e-05	0.0029	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTT1—esophageal cancer	5.06e-05	0.0028	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2A6—esophageal cancer	5e-05	0.00276	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.98e-05	0.00275	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.86e-05	0.00269	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.77e-05	0.00264	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS1—esophageal cancer	4.74e-05	0.00262	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ENO1—esophageal cancer	4.74e-05	0.00262	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.73e-05	0.00262	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PSME2—esophageal cancer	4.67e-05	0.00258	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PSME1—esophageal cancer	4.67e-05	0.00258	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.33e-05	0.00239	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.32e-05	0.00239	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.08e-05	0.00226	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP1B1—esophageal cancer	4.03e-05	0.00223	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.98e-05	0.0022	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP19A1—esophageal cancer	3.79e-05	0.0021	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	3.61e-05	0.002	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMOX1—esophageal cancer	3.46e-05	0.00191	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.39e-05	0.00188	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCB1—esophageal cancer	3.32e-05	0.00184	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.19e-05	0.00177	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.06e-05	0.00169	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.96e-05	0.00164	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.84e-05	0.00157	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.63e-05	0.00146	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.53e-05	0.0014	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.51e-05	0.00139	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CREBBP—esophageal cancer	2.22e-05	0.00123	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.2e-05	0.00122	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.11e-05	0.00117	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.05e-05	0.00113	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NOS3—esophageal cancer	1.98e-05	0.0011	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.9e-05	0.00105	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—esophageal cancer	1.82e-05	0.001	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.69e-05	0.000935	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—EP300—esophageal cancer	1.51e-05	0.000835	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.41e-05	0.00078	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—esophageal cancer	1.12e-05	0.000618	CbGpPWpGaD
